Zydus Lifesciences announced that Usnoflast, a treatment for amyotrophic lateral sclerosis (ALS), has received Orphan Drug Designation from the US FDA. This designation supports the development of ...

Zydus Lifesciences Chairman Pankaj R Patel has been awarded the prestigious Padma Bhushan for his contributions to the ...

Zydus, a leading, discovery-based, global pharmaceutical company announced that the US FDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for the treatment of ...

Zydus Lifesciences has been cleared by the U.S. Food and Drug Administration (FDA) to initiate a Phase 2b trial testing its experimental oral treatment usnoflast in people with amyotrophic lateral ...

“This Orphan Drug Designation from the USFDA underlines the urgent need to develop Usnoflast to address Amyotrophic Lateral Sclerosis (ALS), which is a fatal neurodegenerative disease," said Zydus' ...

The board approved the demerger of the consumer products division of Cadila Healthcare into Carnation, which is a subsidiary of Cadila Healthcare and the merger of Zydus Hospital and Medical ...

Bino Pathiparampil, Head of Research, Elara Capital, says companies like Dr Reddy’s, Zydus, Cipla, Sun, can sustain a low-double digit EPS growth over the medium term. Low-double digit is 11%, 12%, 13 ...

What is a hospital-at-home program? A hospital-at-home (HaH) program involves providing hospitalization services, including 24/7 monitoring, in the comfort of the patient’s home rather than a ...

Nippon India Small Cap Fund (B) 560.96 28,45,731 0.91 Nippon India Small Cap Fund (IDCW) 560.96 28,45,731 0.91 Nippon India Small Cap Fund (G) 560.96 28,45,731 0.91 ...

Zydus Lifesciences: The pharmaceutical company announced the USFDA orphan drug designation to Usnoflast for the treatment of amyotrophic lateral sclerosis. Agro Tech Foods: The CCI approved the ...